User-defined virtual sensor beamforming pinpoints seizure onset zones beyond the temporal lobe, providing a solution for locating epilepsy sources other methods miss.
Cincinnati Children’s leads phase 3 trials of CAP-1002, a cell therapy showing promise for late-stage Duchenne muscular dystrophy patients with limited treatment options.
Discover how Cincinnati Children’s pioneered a surgical approach enabling life-changing gene therapy for AADC deficiency—the youngest patient now thrives.
Discover how Cincinnati Children’s Tuberous Sclerosis Complex Clinic is expanding neurodevelopmental and neuropsychiatric care, including remote behavioral interventions for families nationwide.
Cincinnati Children’s skull base surgery program earns NASBS Multidisciplinary Team of Distinction, showcasing pediatric experts advancing care through collaboration and innovation.
Recent research from Cincinnati Children’s highlights how socioeconomic factors—such as education, income, and insurance—play a critical role in shaping access and outcomes for pediatric MS care.
Cincinnati Children’s offers a team-based approach to surgical tone management in cerebral palsy, including SDR and combined rhizotomy techniques.
The epilepsy team at Cincinnati Children’s is expanding its investment in neuromodulation devices as the next treatment frontier for patients with drug-refractory seizures who aren’t surgical candidates.
A Cincinnati Children’s study finds rising anxiety and depression symptoms in youth with headache disorders, despite stable headache severity over 16 years.